Wetouch Technology Inc Stock (OTC: WETHD)

Latest news for Wetouch Technology Inc (OTC:WETHD) Stock

Wetouch Technology Inc

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) with a Buy and lowers the price target from $20 to $7.

News

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Kezar Life Sciences, Lowers Price Target to $7

Spirit AeroSystems To Release Q2 2024 Financial Results On August 5; Suspends Earnings Conference Calls Due To Merger Agreement With Boeing

Financial giants have made a conspicuous bearish move on HCA Healthcare. Our analysis of options history for HCA Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) revealed 15 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 53% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $466,771, and 6 were calls, valued at $451,229.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $380.0 for HCA Healthcare over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in HCA Healthcare's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to HCA Healthcare's substantial trades, within a strike price spectrum from $300.0 to $380.0 over the preceding 30 days.
<h3>HCA Healthcare 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721672154_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$5.5</td>
<td>$3.7</td>
<td>$5.1</td>
<td>$350.00</td>
<td>$255.0K</td>
<td style="text-align: right;">204</td>
<td>5</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$12.7</td>
<td>$12.2</td>
<td>$12.2</td>
<td>$320.00</td>
<td>$84.1K</td>
<td style="text-align: right;">477</td>
<td>1.3K</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$15.9</td>
<td>$14.8</td>
<td>$15.9</td>
<td>$325.00</td>
<td>$79.5K</td>
<td style="text-align: right;">161</td>
<td>115</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$15.6</td>
<td>$15.2</td>
<td>$15.6</td>
<td>$330.00</td>
<td>$74.8K</td>
<td style="text-align: right;">124</td>
<td>5</td>
</tr>
<tr>
<td>HCA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$4.1</td>
<td>$2.65</td>
<td>$3.0</td>
<td>$355.00</td>
<td>$60.0K</td>
<td style="text-align: right;">57</td>
<td>204</td>
</tr>
</tbody>
</table>

<h3>About HCA Healthcare</h3>
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2022, the firm owned and operated 182 hospitals, 126 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Having examined the options trading patterns of HCA Healthcare, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>HCA Healthcare's Current Market Status</h3>
<ul>
<li>With a trading volume of 835,811, the price of HCA is up by 0.38%, reaching $323.39.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 1 days from now.</li>
</ul>
<h3>What The Experts Say On HCA Healthcare</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $351.2.
<ul>
<li>An analyst from Deutsche Bank has decided to maintain their Buy rating on HCA Healthcare, which currently sits at a price target of $375. </li>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $335. </li>
<li>In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $335. </li>
<li>Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on HCA Healthcare with a target price of $376. </li>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $335.</li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for HCA Healthcare, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

HCA Healthcare Unusual Options Activity For July 22

Whales with a lot of money to spend have taken a noticeably bearish stance on SoFi Techs.
Looking at options history for SoFi Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 64% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $865,453 and 8, calls, for a total amount of $274,270.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $3.0 to $10.0 for SoFi Techs over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for SoFi Techs's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoFi Techs's whale trades within a strike price range from $3.0 to $10.0 in the last 30 days. 
<h3>SoFi Techs Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721672149_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$0.28</td>
<td>$0.27</td>
<td>$0.28</td>
<td>$7.00</td>
<td>$700.0K</td>
<td>9.4K</td>
<td>45.3K</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.55</td>
<td>$4.5</td>
<td>$4.55</td>
<td>$3.00</td>
<td>$45.5K</td>
<td>5.2K</td>
<td>101</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$2.15</td>
<td>$2.1</td>
<td>$2.15</td>
<td>$10.00</td>
<td>$43.0K</td>
<td>15.0K</td>
<td>214</td>
</tr>
<tr>
<td>SOFI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$2.15</td>
<td>$2.1</td>
<td>$2.15</td>
<td>$10.00</td>
<td>$43.0K</td>
<td>15.0K</td>
<td>14</td>
</tr>
<tr>
<td>SOFI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/02/24</td>
<td>$0.12</td>
<td>$0.11</td>
<td>$0.12</td>
<td>$6.50</td>
<td>$38.5K</td>
<td>9.7K</td>
<td>2</td>
</tr>
</tbody>
</table>

<h3>About SoFi Techs</h3>
SoFi is a financial-services company that was founded in 2011 and is based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020, the company also offers payment and account services for debit cards and digital banking.
<h3>Present Market Standing of SoFi Techs</h3>
<ul>
<li>With a volume of 25,950,430, the price of SOFI is down -1.23% at $7.38. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 8 days.</li>
</ul>
<h3>What The Experts Say On SoFi Techs</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $8.333333333333334.
<ul>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for SoFi Techs, targeting a price of $8. </li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $10. </li>
<li>An analyst from Keefe, Bruyette &amp; Woods has decided to maintain their Market Perform rating on SoFi Techs, which currently sits at a price target of $7. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SoFi Techs, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SOFI

Market Whales and Their Recent Bets on SOFI Options

Whales with a lot of money to spend have taken a noticeably bearish stance on Goldman Sachs Gr.
Looking at options history for Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 31% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $370,730 and 11, calls, for a total amount of $520,160.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $400.0 and $720.0 for Goldman Sachs Gr, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Goldman Sachs Gr options trades today is 246.64 with a total volume of 642.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Goldman Sachs Gr's big money trades within a strike price range of $400.0 to $720.0 over the last 30 days.
<h3>Goldman Sachs Gr Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721672144_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$236.65</td>
<td>$229.45</td>
<td>$233.77</td>
<td>$720.00</td>
<td>$116.8K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>GS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$236.7</td>
<td>$229.4</td>
<td>$233.63</td>
<td>$720.00</td>
<td>$116.8K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$72.65</td>
<td>$71.5</td>
<td>$71.5</td>
<td>$450.00</td>
<td>$85.8K</td>
<td style="text-align: right;">385</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/26/24</td>
<td>$86.1</td>
<td>$81.0</td>
<td>$82.03</td>
<td>$405.00</td>
<td>$82.0K</td>
<td style="text-align: right;">11</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$102.15</td>
<td>$99.5</td>
<td>$99.5</td>
<td>$455.00</td>
<td>$79.6K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">8</td>
</tr>
</tbody>
</table>

<h3>About Goldman Sachs Gr</h3>
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
In light of the recent options history for Goldman Sachs Gr, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Goldman Sachs Gr's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 903,274, the GS's price is up by 0.58%, now at $487.75. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 85 days.</li>
</ul>
<h3>What Analysts Are Saying About Goldman Sachs Gr</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $488.0.
<ul>
<li>Maintaining their stance, an analyst from Keefe, Bruyette &amp; Woods continues to hold a Outperform rating for Goldman Sachs Gr, targeting a price of $520. </li>
<li>An analyst from Morgan Stanley persists with their Overweight rating on Goldman Sachs Gr, maintaining a target price of $513. </li>
<li>Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Goldman Sachs Gr, targeting a price of $475. </li>
<li>Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Goldman Sachs Gr with a target price of $373. </li>
<li>An analyst from Oppenheimer has decided to maintain their Outperform rating on Goldman Sachs Gr, which currently sits at a price target of $559. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Goldman Sachs Gr options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Goldman Sachs Gr's Options Frenzy: What You Need to Know

Wedbush analyst Matt Bryson maintains Seagate Tech Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) with a Outperform and raises the price target from $100 to $130.

Wedbush Maintains Outperform on Seagate Tech Hldgs, Raises Price Target to $130

- Reuters Citing Environment And Climate Change Canada

Canadian National Railway Fined $8M For Environmental Offenses Related To 2015 Train Derailments

President Joe Biden&#39;s<a href="https://www.benzinga.com/markets/cannabis/24/07/39874209/joe-biden-drops-out-what-would-happen-with-cannabis-legalization-under-kamala-harris-or-donald-t"> announcement</a> that he will not seek re-election has impacted the cannabis stock market. The sector&#39;s reaction varied, reflecting investor sentiment and market speculation about future regulatory changes under a potential new administration. This analysis, derived from <a href="https://pro.benzinga.com/">Benzinga Pro data</a>, highlights the key movements among popular cannabis stocks 24 hours after the announcement.
<h3>Biggest Losers</h3>
Several cannabis stocks faced a downturn following the announcement. Curaleaf Holdings (OTC: <a class="ticker" href="https://www.benzinga.com/stock/curlf#OTC">CURLF</a>) decreased by 1.3986% to $4.23. Jushi Holdings (OTC: <a class="ticker" href="https://www.benzinga.com/stock/jushf#OTC">JUSHF</a>) dropped by 5.0847%, reaching $0.56. Green Thumb Industries (OTC: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTC">GTBIF</a>) fell by 2.3444% to $11.455. Trulieve Cannabis (OTC: <a class="ticker" href="https://www.benzinga.com/stock/tcnnf#OTC">TCNNF</a>) decreased by 1.1508% to $10.6. Cresco Labs (OTC: <a class="ticker" href="https://www.benzinga.com/stock/crlbf#OTC">CRLBF</a>) dropped by 1.7341%, reaching $1.7.
<h3>Biggest Winners</h3>
Conversely, ohter cannabis stocks saw gains following the announcement. Aurora Cannabis (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) increased by 4.6957%, reaching $6.02. Village Farms International (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) increased by 0.9259%, reaching $1.09. Tilray Brands (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) rose by 4.3575%, reaching $1.868.SNDL (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) saw an increase of 7.1836%, reaching $2.2187.
Medicine Man Technologies (OTC: <a class="ticker" href="https://www.benzinga.com/stock/shwz#OTC">SHWZ</a>) experienced a gain of 100.0%, reaching $0.3. OrganiGram Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ogi#NASDAQ">OGI</a>) rose by 5.1515%, reaching $1.735.
Innovative Industrial Properties (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iipr#NASDAQ">IIPR</a>) gained 1.5641%, reaching $120.13. Cronos Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cron#NASDAQ">CRON</a>) increased by 2.7311%, reaching $2.445. Canopy Growth (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) increased by 9.9593%, reaching $7.8401.&nbsp;
Read Also:<a href="https://www.benzinga.com/markets/cannabis/24/06/39561566/will-bidens-shaky-debate-performance-affect-cannabis-reform-how-a-trump-return-could-reshape-mar">&nbsp;Will Biden&#39;s Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy</a>
<h3>Performance Of Cannabis ETFs</h3>
Cannabis ETFs mirrored the overall market&#39;s mixed sentiment. AdvisorShares Pure Cannabis ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yolo#NYSE">YOLO</a>) rose by 2.0528%, reaching $3.48. AdvisorShares Pure US Cannabis ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/msos#NYSE">MSOS</a>) experienced a gain of 3.9811%, reaching $7.705.
These ETFs remain a barometer for broader market trends within the cannabis sector, indicating cautious optimism among ETF investors.
The trading volumes for these ETFs also showed increased activity, with YOLO trading 15,157 shares and MSOS trading 4,576,010 shares in the last 24 hours.&nbsp;
<img alt="last_24hrs_7_22.jpg" src="https://www.benzinga.com/files/u503488/last_24hrs_7_22.jpg" style="height:293px; width:633px" />
<pre>
*Based on data from <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Read Next: </pre><ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39866755/trump-accepts-gop-nomination-as-party-begins-to-embrace-cannabis-legalization-says-republican-co">Trump Accepts GOP Nomination As Party Begins To Embrace Cannabis Legalization, Says Republican Consultant</a></li>
<li>And:&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39369432/what-is-the-trump-factor-justice-depts-impact-on-cannabis-rescheduling-stocks-and-i">What Is The Trump Factor? Justice Dept&#39;s Impact On Cannabis Rescheduling, Stocks And Investments</a>​​​​​​​</li>
</ul>
These issues will be among the hot topics at the upcoming Benzinga Cannabis Capital Conference in Chicago this Oct. 8-9. Join us to get more insight into what the wave of weed legalization means for the future of investing in the&nbsp;industry. Hear directly from top executives, investors, advocates, and policymakers.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">Get your tickets now</a>&nbsp;before prices go up by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" rel="noreferrer noopener" target="_blank">this link</a>.
Photo: AI-Generated Image.&nbsp;

Cannabis

Government

Market Summary

Penny Stocks

Regulations

Guidance

Politics

Small Cap

Management

Exclusives

Trading Ideas

General

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

IIPR

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

MSOS

SHWZ

SNDL

TCNNF

TLRY

YOLO

Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race

Wedbush analyst Matt Bryson maintains Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) with a Outperform and raises the price target from $85 to $95.

Wedbush Maintains Outperform on Western Digital, Raises Price Target to $95

WIIM

CELH

Celsius Holdings shares are trading lower after B. Riley Securities maintained a Buy rating on the stock but lowered its price target from $110 to $80.

Grammy-winning songwriter <a href="https://www.benzinga.com/markets/cannabis/24/06/39281611/two-new-books-unveil-the-healing-power-of-medical-cannabis">Melissa Etheridge</a> is embroiled in a legal dispute with two former business partners from Northern California, who allege she abandoned their joint cannabis venture, leaving them in financial ruin.
What Happened: Etheridge Farms was launched in 2019 with the idea of providing cannabis products for middle-aged women. 
"They're looking to cannabis, and I want Etheridge Farms to be right there to answer what they're looking for," Etheridge said at the time.
However, by 2024, former partners Josephine and D&#8217;Angelo Roberto claimed that Etheridge and her wife withdrew their support, effectively crippling the business. The Robertos filed a legal petition on July 9, alleging abandonment and financial ruin, <a href="https://www.billboard.com/pro/melissa-etheridge-failed-cannabis-business-legal-dispute/">reported</a> Billboard.
&#8220;The Robertos trusted the Etheridges and invested their life's work into the businesses. Unfortunately, their hard work did not end in a success story, but rather betrayal and abandonment,&#8221; said the Robertos&#8217; attorney Christopher Frost.
Etheridge&#8217;s involvement in cannabis was inspired by her battle with breast cancer in the 2000s. "I came out of chemotherapy saying, I want to be an advocate for this, I believe in this as medicine so deeply," she said.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/06/39281611/two-new-books-unveil-the-healing-power-of-medical-cannabis">Two New Books Unveil The Healing Power Of Medical Cannabis</a>
The partnership initially appeared promising until it didn't. The foursome secured the necessary licenses and a large facility in California where they intended to produce and distribute their products. The business plan foresaw the Robertos providing industry expertise and product development, while the Etheridges would use Melissa's celebrity to promote the brand and attract investors.
The Robertos say they invested all their resources into the business and that the Etheridges failed to do their part. They claim Etheridge did not promote the business as expected and eventually stopped providing financial support, including paying the facility&#8217;s rent, which led to eviction and loss their regulatory licenses.
<h2 class="wp-block-heading">Death Of A Son</h2>
In the midst of this conflict in May 2020, Etheridge announced that her 21-year-old son Beckett Cypher had died from causes related to opioid addiction. Months later, she launched the <a href="https://www.etheridgefoundation.org/">Etheridge Foundation</a> to advocate for and support research into new treatments for opioid addiction.
The Robertos are now seeking damages of at least $3 million compensation for financial hardship caused by the alleged abandonment.
"The Robertos have not pursued this action and are not proceeding to arbitration for fame or fortune or as a vendetta," their lawyers say. "Rather, they simply seek compensation for the suffering they have had to endure and the financial ruin they have experienced due to the Etheridges abandoning them."
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39884184/cannabis-is-flying-off-the-shelves-in-these-five-states-earning-billions-for-marijuana-companies">Cannabis Is Flying Off The Shelves In These Five States, Earning Billions For Marijuana Companies</a></li>
</ul>
Photo: Shutterstock

Legal

Melissa Etheridge Faces Legal Battle Over Failed Cannabis Venture: Former Partners Sue For Millions

Cantor Fitzgerald analyst Andres Sheppard reiterates VinFast Auto (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) with a Overweight and maintains $8 price target.

Reiteration

Cantor Fitzgerald Reiterates Overweight on VinFast Auto, Maintains $8 Price Target

Primega Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) (the "Company"), a provider of transportation services that employs environmentally friendly practices with the aim of facilitating reuse of construction and demolition materials and reduction of construction waste, today announced the pricing of its initial public offering (the "IPO") of 1,500,000 ordinary shares at a public offering price of $4.00 per ordinary share. The Company expects to receive aggregate gross proceeds of approximately $6,000,000 from the IPO, prior to deducting underwriting discounts and other offering expenses. In addition, in connection with the initial public offering, a selling shareholder is offering 250,000 ordinary shares of the Company at $4.00 per share (the "Resale", together with the IPO, the "Offering"), for total gross proceeds of $1,000,000, before deducting underwriting discounts and other offering expenses.
The ordinary shares are expected to begin trading on the Nasdaq Capital Market on July 23, 2024, under the symbol "PGHL." The offering is expected to close on July 24, 2024, subject to customary closing conditions.

IPOs

PGHL

Primega Group Holdings Announces Pricing Of $6M IPO Of 1.5M Ordinary Shares At A Price Of $4/Share

The airline sector was one of the hardest hit by the Microsoft Outage and CrowdStrike (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) <a href="https://www.benzinga.com/news/24/07/39861744/microsoft-outage-what-states-services-companies-saw-the-blue-screen-of-death">issue on Friday.</a>
While the issues have subsided in recent days, one airline may demonstrate its resilience and ability to avoid the outages that impacted its competitors.
What Happened: An <a href="https://www.benzinga.com/markets/equities/24/07/39853528/microsoft-cloud-outage-grounds-flights-disrupts-operations-of-frontier-allegiant-and-sun-country">update by CrowdStrike</a> impacted industries and companies using Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) software and cloud services on Friday.
The airline sector was <a href="https://www.benzinga.com/news/24/07/39875314/crowdstrike-update-for-microsoft-windows-continues-to-cause-chaos-thousands-of-us-flights-canceled-f">hit particularly hard</a> with Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>), United Airline Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) and American Airlines Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) all suffering outages and grounded flights due to the technology issues.
Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) was not impacted by the tech issues and could come through as a winner.
According to a Digital Trends <a href="https://www.digitaltrends.com/computing/southwest-cloudstrike-windows-3-1/">report</a>, Southwest Airlines planes were still operating on Friday as other peers were grounded. The surprising reason is likely the fact that Southwest has been procrastinating on software updates in recent years.
Digital Trends reports that Southwest is using Windows 3.1, an operating system from 1992 from Microsoft.
The report mentioned that some of Southwest&#8217;s systems are still running on Windows 95 and Windows 3.1, which has been a recurring issue, prompting calls for the company to upgrade to newer systems.
"It should go without saying that Southwest needs to update its system, but in this case, the ancient operating systems seem to be doing the airline some favors to avoid a complete Y2K-level apocalypse," Digital Trends writes.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39888488/jim-cramer-applauds-crowdstrikes-response-to-global-it-outage-sees-swift-recovery-ahead-">Jim Cramer Applauds CrowdStrike&#8217;s Response To Global IT Outage, Sees Swift Recovery Ahead: &#8216;It Just Happened To Be Bad Luck&#8217;</a>
Why It's Important: Millions of travelers were impacted by the outage Friday, which led to cancelled flights and delays.
For airline companies, this means they will likely have to issue vouchers, refunds, and other compensations, impacting both current and future revenue. Additionally, they will probably face numerous customer complaints, despite the tech issues often being beyond their control.
Southwest escaping the same customer and revenue issues could set the airline company up well for the future.
The airline company is set to report second-quarter financial results on Thursday. The company could use the earnings report and conference call as an opportunity to highlight its strength in remaining operational during the major tech outage that impacted the sector.
LUV Price Action: Southwest shares are up 1.36% to $27.55 on Monday, versus a 52-week trading range of $21.91 to $37.40. Southwest shares are down 5.1% year-to-date in 2024.
Read Next:
<ul>
<li><a href="https://bzresearch.myclickfunnels.com/latest-research-webinar-redirect-evergreen?utm_source=website-content" target="_blank" rel="noreferrer noopener">Turn Trading Into The Ultimate Side Hustle Using Benzinga Tools In A Free Webinar</a></li>
</ul>
Photo: Around the World Photos/Shutterstock.com

Travel

Tech

CRWD

MSFT

Southwest Airlines Saved By Procrastination: How 32-Year-Old Software Protected Company From Microsoft Outage, CrowdStrike Issues

Cantor Fitzgerald analyst Andres Sheppard reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Overweight and maintains $230 price target.

TSLA

Cantor Fitzgerald Reiterates Overweight on Tesla, Maintains $230 Price Target

Cantor Fitzgerald analyst Andres Sheppard reiterates Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) with a Overweight and maintains $6 price target.

RKLB

Cantor Fitzgerald Reiterates Overweight on Rocket Lab USA, Maintains $6 Price Target

In a week packed with potential market-moving events, 10x Research is cautioning traders against shorting Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), especially in light of <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39867522/trump-campaign-eyes-crypto-voters-what-vp-jd-vances-nomination-means-for-bitcoin">former President Donald Trump&#8216;s</a> upcoming speech at the Bitcoin 2024 conference in Nashville.
What Happened: According to its new <a href="https://mail.10xresearch.co/p/bitcoin-another-alltime-high-attempt-going-parabolic?utm_source=mail.10xresearch.co&amp;utm_medium=newsletter&amp;utm_campaign=bitcoin-another-all-time-high-attempt-before-going-parabolic&amp;last_resource_guid=Post%3A6dfa66ac-8cf3-4bba-ac24-eccb60070969&amp;jwt_token=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWJzY3JpYmVyX2lkIjoiMjlhNTdiZmYtMmVhOC00MTg3LWIzZGItMzk1MGQxMGQ1MmFhIiwiZXhwIjoxNzIxNzc4MzE2LCJpc3MiOiJodHRwczovL2FwcC5iZWVoaWl2LmNvbSIsImlhdCI6MTcyMTYwNTUxNn0.zqbZWp8vz4vnFaB9T_2eg_bvlGetxiTbtouxnYCn5Oc">report</a>, &#8220;Taking profit, or even shorting Bitcoin ahead of Trump&#8217;s Nashville speech, could turn out to be an expensive exercise.&#8221;
The report emphasizes the significance of Bitcoin currently trading near its previous bull market all-time high of $68,300, describing it as &#8220;the line in the sand.&#8221;
The research suggests that if Bitcoin successfully trades above this level, it could trigger a parabolic move similar to previous bull markets. 
&#8220;Bitcoin tended to rise parabolically once above previous all-time highs,&#8221; the report states.
Adding to the anticipation, there are widespread rumors that Trump might announce Bitcoin as a <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39866338/bitcoin-as-a-strategic-reserve-asset-for-the-us-expert-details-how-trump-could-make-it-hap">strategic reserve asset</a> for the U.S. during his speech on July 27.
This potential announcement gains further credibility in light of the current political landscape. 
With President Joe Biden dropping out of the <a href="https://www.benzinga.com/news/24/07/39878848/trump-vs-harris-first-poll-after-bidens-exit-shows-majority-approve-of-decision-but-heres-how-it-mig">U.S. Presidential race</a>, the report suggests that &#8220;no credible candidate can seriously challenge Donald Trump.&#8221;
This scenario could lead to a pro-crypto administration entering the White House, potentially reshaping the U.S. crypto landscape dramatically.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39884149/michelle-obama-for-democratic-nominee-crypto-bettors-think-her-odds-have-just-tripled">Michelle Obama For Democratic Nominee? Crypto Bettors Think Her Odds Have Just Tripled</a>
Why It Matters: The report also highlights the historical precedent of SEC chairs resigning when a new administration is elected.
&#8220;Historically, this meant that the SEC chair resigned when a new administration was elected, despite SEC Chair Gensler&#8216;s term ending on June 5, 2026. He will most likely resign by January/February 2025,&#8221; the report predicts.
Furthermore, the research draws attention to the U.S. government&#8217;s current Bitcoin holdings. 
&#8220;The U.S. government currently holds approximately 212,847 Bitcoins, valued at around $15 billion,&#8221; the report states. It speculates that doubling these holdings could have a significant signaling impact on the market.
While other events such as the <a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39846979/why-ethereum-etfs-mean-it-could-make-a-new-all-time-high-soon">Ethereum ETF launch</a> and U.S. economic reports are on the horizon, the report emphasizes that &#8220;Trump&#8217;s Nashville speech will be essential.&#8221;
As the cryptocurrency market continues to evolve rapidly, investors and industry professionals are eagerly anticipating further developments. 
For those seeking to stay ahead of these trends, Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19 promises to offer valuable insights into the changing landscape of digital currencies and blockchain technology.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39883795/hong-kong-launches-asias-first-bitcoin-futures-inverse-product">Hong Kong Launches Asia&#8217;s First Bitcoin Futures Inverse Product</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Shorting BTC Before Trump's Bitcoin Conference Speech Is A Dangerous Game: 10x Research

Cantor Fitzgerald analyst Andres Sheppard reiterates Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Overweight and maintains $19 price target.

RIVN

Cantor Fitzgerald Reiterates Overweight on Rivian Automotive, Maintains $19 Price Target

SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares are volatile Monday. The stock tumbled last week after the <a href="https://www.benzinga.com/news/24/07/39860503/sunpower-halts-operations-whats-going-on-with-the-stock">company halted shipments and solar installations.</a>
The Details:
SunPower shares fell more than 70% last week after the company informed clients it was halting product shipments and deactivating lease and power purchase agreements. SunPower cited its efforts to address financial challenges as the reason for these pauses, according to Reuters.
Several analysts have downgraded SunPower following the operational halt:&nbsp;
<ul>
<li>GLJ Research analyst Gordon Johnson downgraded SunPower to a Sell and slashed the price target from $1.61 to $0 last Thursday.</li>
<li>Citigroup maintained its Sell rating and lowered the price target from $2.50 to $0.25.</li>
<li>Mizuho downgraded SunPower from Neutral to Underperform and lowered the price target from $4 to $0.50.</li>
<li>JPMorgan Chase analysts led by Mark Strouse stated in a research note that they see the halt as a permanent stoppage for SunPower.&nbsp;</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/07/39860370/serve-robotics-stock-rises-after-nvidia-discloses-10-stake">Serve Robotics Stock Rises After Nvidia Discloses 10% Stake</a>
SunPower shares fell in early trading Monday, but have rebounded higher on heavy trading volume. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, more than 40 million shares have already been traded in Monday's session and 43.9% of shares are being sold short. Stocks with outsized short-interest can experienced increased volatility, especially when combined with heavy trading volume. 
<h2 class="wp-block-heading">How To Buy SPWR Stock: </h2>
By now you're likely curious about how to participate in the market for SunPower &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of SunPower, which is trading at $0.76 as of publishing time, $100 would buy you 131.58 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
SPWR Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, SunPower shares are up 5.1% at 71 cents at the time of publication Monday.
Read Also:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39865576/whats-going-on-with-rivian-stock">What&#8217;s Going On With Rivian Stock?</a></li>
</ul>
Image: Shutterstock

Movers

SPWR

SunPower Stock Attempts To Bounce Back: What's Going On?

On Monday, Rick Barry, the executive chairman of Cassava Sciences Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>), wrote a letter to shareholders and employees.
He said the company is in the final stages of testing its Alzheimer&#8217;s drug candidate, simufilam, with significant financial and emotional stakes.
The company is <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1069530/000143774924023128/ex_701112.htm" rel="noreferrer noopener">conducting</a> Phase 3 trials to demonstrate the drug&#8217;s efficacy and safety.
Related: <a target="_blank" href="https://www.benzinga.com/general/biotech/23/10/35237906/alzheimers-focused-cassava-sciences-faces-controversy-as-key-collaborator-accused-of-scientific-m" rel="noreferrer noopener">Alzheimer&#8217;s-Focused Cassava Sciences Faces Controversy as Key Collaborator Accused of Scientific Misconduct</a>.
These trials, costing hundreds of millions of dollars, are essential for determining if simufilam can significantly impact the lives of Alzheimer&#8217;s patients and their families.
Cassava Sciences&#8217; executive chairman highlights that the first Phase 3 trial, involving 804 patients, is expected to report by December 2024.
The second Phase 3 trial will include 1,125 patients and is anticipated to conclude by June 2025. Both trials are designed to rigorously assess simufilam&#8217;s effectiveness compared to a placebo. The outcome of these trials will be critical in determining the drug&#8217;s future and its potential to alter Alzheimer&#8217;s treatment.
Recently, the Board of Directors appointed Richard (Rick) Barry as Executive Chairman and the company&#8217;s principal executive officer,&nbsp;effective immediately. The company is searching for a new <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39823205/cassava-sciences-faces-leadership-shake-up-prioritizes-transparency-and-scientific-rigor-in-alzhe" rel="noreferrer noopener">permanent CEO</a>.
In July, Cassava Sciences&nbsp;engaged the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC) amid ongoing investigations into the company&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39578081/cassava-sciences-cooperates-with-doj-sec-on-controversial-alzheimers-drug-investigation" rel="noreferrer noopener">and two senior employees</a>.
Cassava's board formed an Ad Hoc Investigation Committee to oversee outside counsel conducting the investigation. The Committee also oversees the company's disclosures related to the investigation, the company&nbsp;<a target="_blank" href="https://www.benzinga.com/secfilings/24/07/39572761/cassava-sciences-inc-general-corporate-statement-form8" rel="noreferrer noopener">said</a> in an SEC filing.
The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection <a target="_blank" href="https://www.benzinga.com/news/24/03/37605163/alzheimers-drug-trial-results-questioned-after-damning-fda-inspection-report" rel="noreferrer noopener">report by the FDA</a>.
The FDA report, which was released under the Freedom of Information Act, highlighted several issues with the clinical trial work conducted by pharmacologist&nbsp;Hoau-Yan Wang at the City University of New York (CUNY),&nbsp;reported&nbsp;Science.org.
Price Action: SAVA stock is trading 22.7% higher at $12.37 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39885871/iqvia-is-a-solid-investment-with-strong-competitive-positioning-analyst-says-after-" target="_blank" rel="noreferrer noopener">IQVIA &#8216;Is A Solid Investment&#8217; With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings</a>.</li>
</ul>

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Wetouch Technology Inc

News

Latest news for Wetouch Technology Inc (OTC:WETHD) Stock